PL2444081T3 - Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol - Google Patents

Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol

Info

Publication number
PL2444081T3
PL2444081T3 PL11008419T PL11008419T PL2444081T3 PL 2444081 T3 PL2444081 T3 PL 2444081T3 PL 11008419 T PL11008419 T PL 11008419T PL 11008419 T PL11008419 T PL 11008419T PL 2444081 T3 PL2444081 T3 PL 2444081T3
Authority
PL
Poland
Prior art keywords
cannabidiol
treatment
composition
inflammatory diseases
boswellic acid
Prior art date
Application number
PL11008419T
Other languages
English (en)
Inventor
Jirí Skalicky
Jirí Husek
Jana Hofbauerová
Milan Dittrich
Original Assignee
Parenteral A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20100764A external-priority patent/CZ2010764A3/cs
Priority claimed from CZ20110541A external-priority patent/CZ2011541A3/cs
Application filed by Parenteral A S filed Critical Parenteral A S
Publication of PL2444081T3 publication Critical patent/PL2444081T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL11008419T 2010-10-19 2011-10-19 Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol PL2444081T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20100764A CZ2010764A3 (cs) 2010-10-19 2010-10-19 Kompozice pro lécbu zánetlivých onemocnení
CZ20110541A CZ2011541A3 (cs) 2011-08-30 2011-08-30 Kompozice pro lécbu zánetlivých onemocnení
EP11008419.1A EP2444081B1 (en) 2010-10-19 2011-10-19 A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol

Publications (1)

Publication Number Publication Date
PL2444081T3 true PL2444081T3 (pl) 2015-09-30

Family

ID=45033650

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11008419T PL2444081T3 (pl) 2010-10-19 2011-10-19 Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol

Country Status (4)

Country Link
EP (1) EP2444081B1 (pl)
ES (1) ES2541485T3 (pl)
HU (1) HUE026929T2 (pl)
PL (1) PL2444081T3 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3232808B1 (de) * 2014-12-19 2020-04-01 THC Pharm GmbH The Health Concept Cbd-haltiges getränk
AU2016226267A1 (en) 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US11369655B2 (en) 2015-07-06 2022-06-28 Cg-Bio Genomics, Inc. Healthful supplements
GB2542797A (en) 2015-09-29 2017-04-05 Gw Pharma Ltd Use of cannabinoids in the treatment of inflammatory skin diseases
LT6485B (lt) 2016-04-04 2018-01-10 UAB "SatiMed" Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui
JP2019523282A (ja) * 2016-08-03 2019-08-22 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 大麻組成物
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
JP2020508991A (ja) * 2017-02-15 2020-03-26 ボタニクス ファーマシューティカルズ リミテッド 乾癬の処置のためのカンナビノイドの製剤
CN110769819A (zh) * 2017-02-15 2020-02-07 博塔尼克斯制药有限公司 用于治疗痤疮的大麻素制剂
IL268720B2 (en) * 2017-02-15 2024-09-01 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
WO2019109131A1 (en) * 2017-12-04 2019-06-13 Botanix Pharmaceuticals Ltd Antibacterial treatment using cannabinoids
WO2019144189A1 (en) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for acne
AU2019210704A1 (en) * 2018-01-24 2020-08-06 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for psoriasis
CN111936126A (zh) * 2018-01-24 2020-11-13 博塔尼克斯制药有限公司 用于皮炎和炎症性皮肤病的大麻素给药方案
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US20190240148A1 (en) * 2018-02-07 2019-08-08 Tarukino Holdings, Inc. Lubricant composition and method for preparing the composition
KR102041876B1 (ko) * 2018-02-14 2019-11-08 (주)카이언바이오텍 칸나비디올 또는 그 유도체를 함유하는 아토피 개선용 화장료 조성물
IT201800005002A1 (it) * 2018-05-02 2019-11-02 Composizioni comprendenti estratti di boswellia e butirrati
CA3105082A1 (en) * 2018-07-02 2020-01-09 Companion Sciences, Llc Cannabidiol combination compositions
US10668045B2 (en) * 2018-07-12 2020-06-02 Bright Green Corporation Topical massage oil and cream containing CBD, CBN, curcumin and Boswellia resin
EP3843765A4 (en) * 2018-08-27 2022-06-01 Emerald Health Therapeutics Canada Inc. THERAPEUTIC COMBINATIONS OF BOSWELLIA EXTRACT AND CANNABINOIDS
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
US20210393574A1 (en) * 2018-11-12 2021-12-23 Hanyi Bio-Technology (Beijing) Co., Ltd. Use of cannabinoid compound in neurodermatitis treatment
IT201900003325A1 (it) * 2019-03-07 2020-09-07 C I A M S R L Composizione per la prevenzione e trattamento della dermatite atopica
WO2020232530A1 (en) * 2019-05-22 2020-11-26 Canopy Growth Corporation Cannabinoid-comprising compositions for management of pain
CN110269839A (zh) * 2019-06-15 2019-09-24 云南飞久逍科技有限公司 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用
IT201900016709A1 (it) * 2019-09-19 2021-03-19 Aqma Italia S P A Composizione antidolorifica e antinfiammatoria ad uso locale
CA3150913A1 (en) * 2019-10-07 2021-04-15 Colgate-Palmolive Company Personal care compositions and methods
EP4017470A1 (en) 2019-12-16 2022-06-29 Colgate-Palmolive Company Personal care compositions and methods for the same
ES2987036T3 (es) * 2019-12-16 2024-11-13 Mehmet Nevzat Pisak Composiciones cannabinoides con alta solubilidad y biodisponibilidad
IT202000024217A1 (it) 2020-10-14 2022-04-14 Sanitas Laboratorio Chimico Farm S R L Composizione farmaceutica ad effetto analgesico a base di acmella olearacea ed altri principi attivi
CN113521004B (zh) * 2021-06-24 2022-02-22 中国农业科学院农产品加工研究所 一种高负载大麻二酚水包油大分子颗粒乳液的制备方法
BE1028576B1 (fr) * 2021-12-30 2023-08-17 Dyna S A R L Composition comprenant au moins un acide boswellique et/ou au moins un extrait végétal comprenant au moins un acide boswellique pour utilisation topique dans le traitement des maladies inflammatoires de la peau
US12233043B1 (en) 2022-07-12 2025-02-25 Florida A&M University Method of transdermal delivery of cannabinoid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
US20080255224A1 (en) * 2007-04-16 2008-10-16 Blum Richard S Pharmacological treatment of psoriasis
AU2009263735B2 (en) * 2008-06-03 2014-10-02 Laila Nutraceuticals Compositions comprising extracts from Boswellia serrata
US20100273895A1 (en) * 2009-04-28 2010-10-28 Alltranz Inc. Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same

Also Published As

Publication number Publication date
HUE026929T2 (en) 2016-08-29
EP2444081A1 (en) 2012-04-25
ES2541485T3 (es) 2015-07-21
EP2444081B1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
HUE037600T2 (hu) Vegyületek és készítmények paraziták által okozott fertõzések kezelésére
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
CO6940374A2 (es) Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas
PT3400944T (pt) Inibidores do ibat para o tratamento de doenças hepáticas
EP2621499A4 (en) METHODS OF TREATING ALLERGIC DISEASES
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
PT3321355T (pt) Métodos e composições para a derivação clínica de uma célula alogénica e utilizações terapêuticas
HRP20181462T1 (hr) Kombinacija regorafeniba i acetilsalicilne kiseline za liječenje raka debelog crijeva
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
PL2780036T3 (pl) Kompozycje nanocząstek do generowania regulatorowych komórek t i leczenie chorób autoimmunologicznych i innych przewlekłych stanów zapalnych
PL3443957T3 (pl) Związki i kompozycje stosowane w leczeniu nowotworów
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
PL2627345T3 (pl) Preparaty do leczenia chorób górnych dróg oddechowych
PL2613798T3 (pl) Zastosowanie lizosomalnej kwaśnej lipazy do leczenia niedoboru lizosomalnej kwaśnej lipazy u pacjentów
EE201300007A (et) Kombineeritud ravimkoostis diabeedi ning ainevahetush„irete raviks
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
PT2525796T (pt) Solução aquosa incluindo 3-quinuclidinonas para o tratamento de doenças hiperproliferativas, auto-imunes e cardíacas
EP2852570A4 (en) Compositions and methods for the treatment of inflammatory bowel disease
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks